secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001562762-23-000046
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q4 net sales $274.5M (+9.8% YoY); full year exceeds $1B; guides 2023 sales $1.1B
--------------------------------------------------------------------------------

- Q4 GAAP diluted EPS $0.49, non-GAAP diluted EPS $0.59; net income $50.1M (+231% YoY).
- Full year 2022 net sales $1,022.8M (+6.8% YoY); GAAP diluted EPS $1.85, non-GAAP $2.06.
- Non-GAAP adjusted EBITDA Q4 $90.2M (32.8% of sales); full year $339.2M (33.2%).
- 2023 guidance: net sales ~$1.1B, non-GAAP diluted EPS $2.30.
- Company remains debt-free; net cash from ops $178.5M, free cash flow $104.4M for full year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276223000046/0001562762-23-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276223000046/gmed-20230221x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-23-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer